These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20938137)

  • 1. Management of anemia by convective treatments.
    Locatelli F; Manzoni C; Del Vecchio L; Di Filippo S; Pontoriero G; Cavalli A
    Contrib Nephrol; 2011; 168():162-172. PubMed ID: 20938137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dialysis adequacy and response to erythropoietic agents: what is the evidence base?
    Locatelli F; Del Vecchio L
    Nephrol Dial Transplant; 2003 Nov; 18 Suppl 8():viii29-35. PubMed ID: 14607998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis adequacy and response to erythropoiesis-stimulating agents: what is the evidence base?
    Locatelli F; Del Vecchio L; Pozzoni P; Andrulli S
    Semin Nephrol; 2006 Jul; 26(4):269-74. PubMed ID: 16949464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing dose and mode of renal replacement therapy in anaemia management.
    Locatelli F
    Nephrol Dial Transplant; 2002; 17 Suppl 5():60-5. PubMed ID: 12091610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a More Permeable Dialysis Membrane on ESA Resistance in Hemodialysis Patients--A Pilot Investigation.
    Teatini U; Liebchen A; Nilsson LG; Beck W; Longhena GR
    Blood Purif; 2016; 41(1-3):80-6. PubMed ID: 26536083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized pilot study on the effects of two synthetic high-flux dialyzers on dialysis patient anemia.
    Viganò SM; Filippo SD; Milia VL; Pontoriero G; Locatelli F
    Int J Artif Organs; 2012 May; 35(5):346-51. PubMed ID: 22684617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of high-volume online mixed-hemodiafiltration on anemia management in dialysis patients.
    Pedrini LA; Zawada AM; Winter AC; Pham J; Klein G; Wolf M; Feuersenger A; Ruggiero P; Feliciani A; Barbieri C; Gauly A; Canaud B; Stuard S
    PLoS One; 2019; 14(2):e0212795. PubMed ID: 30794672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenge of effectively using erythropoiesis-stimulating agents and intravenous iron.
    Kapoian T
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S21-8. PubMed ID: 19010258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin variability in dialysis patients.
    Brimble KS; Clase CM
    J Am Soc Nephrol; 2007 Aug; 18(8):2218-20. PubMed ID: 17627931
    [No Abstract]   [Full Text] [Related]  

  • 11. High-volume online haemodiafiltration improves erythropoiesis-stimulating agent (ESA) resistance in comparison with low-flux bicarbonate dialysis: results of the REDERT study.
    Panichi V; Scatena A; Rosati A; Giusti R; Ferro G; Malagnino E; Capitanini A; Piluso A; Conti P; Bernabini G; Migliori M; Caiani D; Tetta C; Casani A; Betti G; Pizzarelli F
    Nephrol Dial Transplant; 2015 Apr; 30(4):682-9. PubMed ID: 25385719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized anemia management in a dialysis facility - long-term utility as a single-center quality improvement experience
.
    Gaweda AE; Jacobs AA; Aronoff GR; Brier ME
    Clin Nephrol; 2018 Oct; 90(4):276-285. PubMed ID: 30049300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane requirements for high-flux and convective therapies.
    Bowry SK
    Contrib Nephrol; 2011; 175():57-68. PubMed ID: 22188688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities.
    Meert N; Eloot S; Schepers E; Lemke HD; Dhondt A; Glorieux G; Van Landschoot M; Waterloos MA; Vanholder R
    Nephrol Dial Transplant; 2011 Aug; 26(8):2624-30. PubMed ID: 21310741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Lowering Haemoglobin Targets on Patterns of Erythropoiesis-Stimulating Agent Use in Patients on Haemodialysis.
    Hazara AM; Owen SJ; Bhandari S
    Blood Purif; 2016; 41(4):287-92. PubMed ID: 26820617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients.
    Barbieri C; Bolzoni E; Mari F; Cattinelli I; Bellocchio F; Martin JD; Amato C; Stopper A; Gatti E; Macdougall IC; Stuard S; Canaud B
    PLoS One; 2016; 11(3):e0148938. PubMed ID: 26939055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive vision for intravenous iron therapy.
    Coyne DW
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Erythropoietin-Stimulating Agents (ESA) in Patients With End-Stage Renal Failure Decided to Forego Dialysis: Palliative Perspective.
    Cheng HW; Chan KY; Lau HT; Man CW; Cheng SC; Lam C
    Am J Hosp Palliat Care; 2017 May; 34(4):380-384. PubMed ID: 26718957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a change in erythropoiesis-stimulating agent dose during hospitalization and subsequent hemoglobin levels and transfusions in hemodialysis patients.
    Wong BC; Ravani P; Manns BJ; Lewin A; Zhang X; Chin R; Hemmelgarn BR; Tonelli M; Oliver MJ; Quinn RR
    Am J Kidney Dis; 2013 Nov; 62(5):947-52. PubMed ID: 23856380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Opatija study: observation of hemodialysis patients and titration of CERA dose just switched from another erythropoiesis stimulating agent].
    Jelić I; Lovcić V; Kurtović I; Josipović M; Havranek Z; Kostić L; Racki S
    Acta Med Croatica; 2012 Jul; 66(3):157-64. PubMed ID: 23441529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.